作者: Shivani Mittal , Shrikant Pradhan , Tapasya Srivastava
DOI: 10.1586/14737175.2015.1061934
关键词: Brain tumor 、 Oncology 、 Targeted therapy 、 Clinical trial 、 Regimen 、 Drug development 、 Temozolomide 、 Medicine 、 Internal medicine 、 Radiation therapy 、 Standard treatment 、 Pharmacology
摘要: … Of all the known tumors, GBM is the most challenging because of its infiltrating nature, recurrence tendencies and resistance to chemotherapy. Its treatment continues to remain …